STAAR Surgical China

STAAR Surgical Company (an S&P 400 midcap company trading under NASDAQ: STAA), a leading developer, manufacturer and marketer of implantable lenses and companion delivery systems for the eye has been dedicated solely to ophthalmic surgery for over 35 years. The company offers the EVO implantable Collamer® lenses (ICLs) to treat visual disorders, such as myopia and astigmatism. These lenses are intended to provide visual freedom for patients, lessening or eliminating the reliance on glasses or contact lenses. All of these lenses are foldable, which permits the surgeon to insert them through a small incision. STAAR's lens used in refractive surgery is called an Implantable Collamer Lens or "ICL". Over 3,000,000 EVO ICLs have been implanted to date. STAAR Surgical China has been committed to achieving our vision of "The first choice for Doctors and Patients Seeking Visual Freedom." And using EVO ICL to help our patients seeking visual freedom. STAAR Surgical是一家生产、销售眼科医疗产品的高科技的全球性企业，也是纳斯达克上市公司。 STAAR Surgical公司的EVO ICL晶体植入术为全球视力矫正领域带来革命性的突破，具有视觉质量高、不切削角膜、保留眼球完整性的特点。晶体材料Collamer为STAAR Surgical公司的专利材料。迄今为止，ICL全球植入量已经超过300万枚。 STAAR Surgical China一直致力于实现"成为医生和患者视力自由的首选"的愿景，并通过EVO ICL来帮助我们的病人获得视觉自由。

• Employees 5